Published July 4, 2016 | Version v1
Journal article

Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes

  • 1. Laboratory Bld. 5. etg, Bergen Health, Bergen, NO-5021 (Norway)
  • 2. Department of Clinical Science, University of Bergen, Bergen (Norway)
  • 3. Centre for Cancer Biomarkers, University of Bergen, Bergen (Norway)
  • 4. Department of Microbiology, Haukeland University Hospital, Bergen (Norway)
  • 5. Cancer Institute, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of (China)
  • 6. Department of Urology, University of Washington, Seattle, WA (United States)

Description

Expression of the androgen receptor (AR) is associated with androgen-dependent proliferation arrest and terminal differentiation of normal prostate epithelial cells. Additionally, activation of the AR is required for survival of benign luminal epithelial cells and primary cancer cells, thus androgen deprivation therapy (ADT) leads to apoptosis in both benign and cancerous tissue. Escape from ADT is known as castration-resistant prostate cancer (CRPC). In the course of CRPC development the AR typically switches from being a cell-intrinsic inhibitor of normal prostate epithelial cell proliferation to becoming an oncogene that is critical for prostate cancer cell proliferation. A clearer understanding of the context dependent activation of the AR and its target genes is therefore desirable. Immortalized human prostate basal epithelial EP156T cells and progeny cells that underwent epithelial to mesenchymal transition (EMT), primary prostate epithelial cells (PrECs) and prostate cancer cell lines LNCaP, VCaP and 22Rv1 were used to examine context dependent restriction and activation of the AR and classical target genes, such as KLK3. Genome-wide gene expression analyses and single cell protein analyses were applied to study the effect of different contexts. A variety of growth conditions were tested and found unable to activate AR expression and transcription of classical androgen-dependent AR target genes, such as KLK3, in prostate epithelial cells with basal cell features or in mesenchymal type prostate cells. The restriction of androgen- and AR-dependent transcription of classical target genes in prostate basal epithelial cells was at the level of AR expression. Exogenous AR expression was sufficient for androgen-dependent transcription of AR target genes in prostate basal epithelial cells, but did not exert a positive feedback on endogenous AR expression. Treatment of basal prostate epithelial cells with inhibitors of epigenetic gene silencing was not efficient in inducing androgen-dependent transcription of AR target genes, suggesting the importance of missing cofactor(s). Regulatory mechanisms of AR and androgen-dependent AR target gene transcription are insufficiently understood and may be critical for prostate cancer initiation, progression and escape from standard therapy. The present model is useful for the study of context dependent activation of the AR and its transcriptome. The online version of this article (doi:10.1186/s12885-016-2453-4) contains supplementary material, which is available to authorized users

Availability note (English)

Available from http://dx.doi.org/10.1186/s12885-016-2453-4; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932678

Additional details

Publishing Information

Journal Title
BMC cancer (Online)
Journal Volume
16
Journal Page Range
vp.
ISSN
1471-2407

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47088117
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ANDROGENS; CASTRATION; CELL PROLIFERATION; NEOPLASMS; PROSTATE; RECEPTORS; STEM CELLS; TRANSCRIPTION
Descriptors DEC
ANDROSTANES; ANIMAL CELLS; BODY; DISEASES; GLANDS; HORMONES; MALE GENITALS; MEDICINE; MEMBRANE PROTEINS; ORGANIC COMPOUNDS; ORGANS; PROTEINS; SOMATIC CELLS; STEROID HORMONES; STEROIDS; SURGERY

Optional Information

Copyright
Copyright (c) The Author(s). 2016
Notes
PMCID: PMC4932678; PMID: 27378372; PUBLISHER-ID: 2453; OAI: oai:pubmedcentral.nih.gov:4932678